Ning Zheng | |
---|---|
Alma mater | |
Known for | |
Awards | |
Scientific career | |
Institutions | University of Washington Howard Hughes Medical Institute |
Thesis | A Tale of Two Ligands: Signal Sequence Recognition by E. coli Signal Sequence Recognition Particle with its Indispensable RNA Component (1997) |
Doctoral advisor | Lila Gierasch |
Other academic advisors | Nikola Pavletich |
Website | https://depts.washington.edu/zhenglab/ |
Ning Zheng is an experimental structural biologist and protein biochemist known for his pioneering work in the fields of molecular glues and targeted protein degradation. He is currently a professor in the Department of Pharmacology at the University of Washington School of Medicine and a Howard Hughes Medical Institute (HHMI) Investigator. [1] [2]
The son of a Chinese biochemistry professor, Ning Zheng obtained his Ph.D. in 1997 from the University of Texas Southwestern Medical Center. [3] [4]
He completed his postdoctoral studies at the Memorial Sloan-Kettering Cancer Center under the mentorship of Nikola Pavletich, where he published two seminal studies on the atomic structures of prototypical human ubiquitin ligase complexes. [5] [6] These studies laid the foundation for his subsequent research and contributions to structural biology and protein ubiquitination.
Ning Zheng’s research focuses on the molecular and structural mechanisms by which protein-protein interactions regulate eukaryotic biology and human diseases. His laboratory has made significant contributions to understanding the cullin-RING superfamily of E3 ubiquitin ligases, which is implicated in a myriad of cellular functions such as signal transduction, cell cycle regulation, transcriptional control, and DNA repair. [7]
Zheng's recent studies have expanded to several areas of life sciences, including protein degradation, plant hormone signaling, circadian clock regulation, chromatin modification, and the structure-function relationships of ion channels and transporters. [7] His groundbreaking work on the perception mechanism of the plant hormone auxin led to the introduction of the concept of "molecular glue." [8] [9] This concept describes how monovalent small molecules can promote protein-protein interactions by complementing protein interfaces, facilitating targeted-protein degradation. [10] This conceptual advance has become instrumental in the development of novel therapeutic compounds for targeting disease-causing proteins considered undruggable. [11] His laboratory is actively involved in drug discovery programs aimed at treating challenging human diseases, such as cancers and neurodegenerative disorders. [7]
Throughout his career, Ning Zheng has received numerous accolades. After joining the faculty of Pharmacology at the University of Washington, he was awarded the Pew Scholar Award and the Burroughs Welcome Investigator Award in Pathogenesis of Infectious Diseases. [12] [13] In 2008, he became a Howard Hughes Medical Institute Investigator. [2] He was promoted to Professor in 2012. [1] [14] His significant contributions to science have been recognized through his election as a Fellow of the American Association for the Advancement of Science (AAAS) in 2015 and as a member of the Washington State Academy of Science in 2020. [15] [16]
Auxins are a class of plant hormones with some morphogen-like characteristics. Auxins play a cardinal role in coordination of many growth and behavioral processes in plant life cycles and are essential for plant body development. The Dutch biologist Frits Warmolt Went first described auxins and their role in plant growth in the 1920s. Kenneth V. Thimann became the first to isolate one of these phytohormones and to determine its chemical structure as indole-3-acetic acid (IAA). Went and Thimann co-authored a book on plant hormones, Phytohormones, in 1937.
A ubiquitin ligase is a protein that recruits an E2 ubiquitin-conjugating enzyme that has been loaded with ubiquitin, recognizes a protein substrate, and assists or directly catalyzes the transfer of ubiquitin from the E2 to the protein substrate. In simple and more general terms, the ligase enables movement of ubiquitin from a ubiquitin carrier to another protein by some mechanism. The ubiquitin, once it reaches its destination, ends up being attached by an isopeptide bond to a lysine residue, which is part of the target protein. E3 ligases interact with both the target protein and the E2 enzyme, and so impart substrate specificity to the E2. Commonly, E3s polyubiquitinate their substrate with Lys48-linked chains of ubiquitin, targeting the substrate for destruction by the proteasome. However, many other types of linkages are possible and alter a protein's activity, interactions, or localization. Ubiquitination by E3 ligases regulates diverse areas such as cell trafficking, DNA repair, and signaling and is of profound importance in cell biology. E3 ligases are also key players in cell cycle control, mediating the degradation of cyclins, as well as cyclin dependent kinase inhibitor proteins. The human genome encodes over 600 putative E3 ligases, allowing for tremendous diversity in substrates.
Skp, Cullin, F-box containing complex is a multi-protein E3 ubiquitin ligase complex that catalyzes the ubiquitination of proteins destined for 26S proteasomal degradation. Along with the anaphase-promoting complex, SCF has important roles in the ubiquitination of proteins involved in the cell cycle. The SCF complex also marks various other cellular proteins for destruction.
F-box proteins are proteins containing at least one F-box domain. The first identified F-box protein is one of three components of the SCF complex, which mediates ubiquitination of proteins targeted for degradation by the 26S proteasome.
S-phase kinase-associated protein 2 is an enzyme that in humans is encoded by the SKP2 gene.
Cullin 1, also known as CUL1, is a human protein and gene from cullin family. This protein plays an important role in protein degradation and protein ubiquitination.
NEDD8 is a protein that in humans is encoded by the NEDD8 gene. This ubiquitin-like (UBL) protein becomes covalently conjugated to a limited number of cellular proteins, in a process called NEDDylation similar to ubiquitination. Human NEDD8 shares 60% amino acid sequence identity to ubiquitin. The primary known substrates of NEDD8 modification are the cullin subunits of cullin-based E3 ubiquitin ligases, which are active only when NEDDylated. Their NEDDylation is critical for the recruitment of E2 to the ligase complex, thus facilitating ubiquitin conjugation. NEDD8 modification has therefore been implicated in cell cycle progression and cytoskeletal regulation.
RING-box protein 1 is a protein that in humans is encoded by the RBX1 gene.
Cullin-4A is a protein that in humans is encoded by the CUL4A gene. CUL4A belongs to the cullin family of ubiquitin ligase proteins and is highly homologous to the CUL4B protein. CUL4A regulates numerous key processes such as DNA repair, chromatin remodeling, spermatogenesis, haematopoiesis and the mitotic cell cycle. As a result, CUL4A has been implicated in several cancers and the pathogenesis of certain viruses including HIV. A component of a CUL4A complex, Cereblon, was discovered to be a major target of the teratogenic agent thalidomide.
Cullin-5 is a protein that in humans is encoded by the CUL5 gene.
Cullin-2 is a protein that in humans is encoded by the CUL2 gene.
Cullin-4B is a protein that in humans is encoded by the CUL4B gene which is located on the X chromosome. CUL4B has high sequence similarity with CUL4A, with which it shares certain E3 ubiquitin ligase functions. CUL4B is largely expressed in the nucleus and regulates several key functions including: cell cycle progression, chromatin remodeling and neurological and placental development in mice. In humans, CUL4B has been implicated in X-linked intellectual disability and is frequently mutated in pancreatic adenocarcinomas and a small percentage of various lung cancers. Viruses such as HIV can also co-opt CUL4B-based complexes to promote viral pathogenesis. CUL4B complexes containing Cereblon are also targeted by the teratogenic drug thalidomide.
Cullin 3 is a protein that in humans is encoded by the CUL3 gene.
RING-box protein 2 is a protein that in humans is encoded by the RNF7 gene.
Cullin-associated NEDD8-dissociated protein 1 is a protein that in humans is encoded by the CAND1 gene.
Cullins are a family of hydrophobic scaffold proteins which provide support for ubiquitin ligases (E3). All eukaryotes appear to have cullins. They combine with RING proteins to form Cullin-RING ubiquitin ligases (CRLs) that are highly diverse and play a role in myriad cellular processes, most notably protein degradation by ubiquitination.
S-phase kinase-associated protein 1 is an enzyme that in humans is encoded by the SKP1 gene.
Raymond Joseph Deshaies is an American biochemist and cell biologist. He is senior vice president of global research at Amgen and a visiting associate at the California Institute of Technology (Caltech). Prior to that, he was a professor of biology at Caltech and an investigator of the Howard Hughes Medical Institute. He is also the co-founder of the biotechnology companies Proteolix and Cleave Biosciences. His research focuses on mechanisms and regulation of protein homeostasis in eukaryotic cells, with a particular focus on how proteins are conjugated with ubiquitin and degraded by the proteasome.
Molecular glue refers to a class of chemical compounds or molecules that play a crucial role in binding and stabilizing protein-protein interactions in biological systems. These molecules act as "glue" by enhancing the affinity between proteins, ultimately influencing various cellular processes. Molecular glue compounds have gained significant attention in the fields of drug discovery, chemical biology, and fundamental research due to their potential to modulate protein interactions, and thus, impact various cellular pathways. They have unlocked avenues in medicine previously thought to be "undruggable".
Nicolas H. Thomä is a German researcher, full professor at the EPFL School of Life Sciences and Director of the Paternot Chair for Cancer Research in Lausanne, Switzerland. He is a biochemist and structural biologist and a leading researcher in the fields of ubiquitin ligase biology and DNA repair.